Ultima CJC-1295 DAC is a premium research-grade growth hormone releasing hormone analog. This modified peptide features Drug Affinity Complex (DAC) technology for extended half-life and sustained activity. The Ultima DAC compound enables researchers to study prolonged growth hormone release patterns and their effects over extended periods.
Research Applications
This CJC-1295 DAC peptide supports long-term research investigations:
Sustained growth hormone release studies
Long-term metabolic research projects
Extended muscle growth observations
Prolonged recovery mechanism analysis
Chronic endocrine system studies
Key Features
DAC technology for extended half-life
2mg precision research dosage
Third-party tested for ≥99% purity
Sustained activity for long-term studies
Research-grade manufacturing standards
Safety Information
This Ultima product is for research use only. It is not for human consumption. Researchers must follow all laboratory safety protocols when handling this material.
Why Choose Ultima?
Our long-acting research peptide undergoes rigorous third-party testing. The DAC technology provides sustained release properties ideal for chronic study models.
Be the first to review “Ultima CJC-1295 DAC”
Related products
Reviews
There are no reviews yet.